Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients

Respiratory Medicine

Volumn 106, Issue 3, 2012, Pages 443-450

  Kang, Hyo Jae ^a   Park, Jong Sun ^a   Kim, Dong Wan ^a   Lee, Jinwoo ^a   Jeong, Yun Jeong ^a   Choi, Sun Mi ^a   Lee, Sang Min ^a   Yang, Seok Chul ^a   Yoo, Chul Gyu ^a   Kim, Young Whan ^a   Han, Sung Koo ^a   Yim, Jae Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Adverse pulmonary reaction; Anticancer chemotherapy; Bevacizumab; Cetuximab; Rituximab; Trastuzumab

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; IRINOTECAN; MONOCLONAL ANTIBODY; OXALIPLATIN; PREDNISOLONE; RITUXIMAB; TRASTUZUMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; DRUG INDICATION; FEMALE; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; LUNG COMPLICATION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEOPLASMS; OPPORTUNISTIC INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN;

EID: 84855872226     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.11.009     Document Type: Article

References (23)

1. B. Vahid, and P.E. Marik Pulmonary complications of novel antineoplastic agents for solid tumors Chest 133 2 2008 528 538 (Pubitemid 351272414)
2. A.G. Charpidou, I. Gkiozos, S. Tsimpoukis, D. Apostolaki, K.D. Dilana, and E.M. Karapanagiotou Therapy-induced toxicity of the lungs: an overview Anticancer Res 29 2 2009 631 639
3. G. Walsh Biopharmaceutical benchmarks 2006 Nat Biotechnol 24 7 2006 769 776 (Pubitemid 44086612)
4. T.J. Giezen, A.K. Mantel-Teeuwisse, S.M. Straus, H. Schellekens, H.G. Leufkens, and A.C. Egberts Safety-related regulatory actions for biologicals approved in the United States and the European Union JAMA 300 16 2008 1887 1896
5. T.A. Waldmann Immunotherapy: past, present and future Nat Med 9 3 2003 269 277 (Pubitemid 36362781)
6. X. Liu, X.N. Hong, Y.J. Gu, B.Y. Wang, Z.G. Luo, and J. Cao Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma Leuk Lymphoma 49 9 2008 1778 1783
7. J.B. Hoag, A. Azizi, T.J. Doherty, J. Lu, R.E. Willis, and M.E. Lund Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review J Exp Clin Cancer Res 28 2009 113
8. S.A. Wagner, A.C. Mehta, and D.A. Laber Rituximab-induced interstitial lung disease Am J Hematol 82 10 2007 916 919 (Pubitemid 47502698)
9. Y. Herishanu, A. Polliack, L. Leider-Trejo, Y. Grieff, U. Metser, and E. Naparstek Fatal interstitial pneumonitis related to rituximab-containing regimen Clin Lymphoma Myeloma 6 5 2006 407 409
10. J.I. Lai, W.S. Wang, Y.C. Lai, P.C. Lin, and S.C. Chang Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy Int J Clin Pharmacol Ther 48 7 2010 425 428
11. W. Chua, M. Peters, R. Loneragan, and S. Clarke Cetuximab-associated pulmonary toxicity Clin Colorectal Cancer 8 2 2009 118 120
12. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl. 2 2007 S27 S72
13. W.S. Lim, S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, and I. Le Jeune BTS guidelines for the management of community acquired pneumonia in adults: update 2009 Thorax 64 Suppl. 3 2009 1 55 iii
14. S. Aida, S. Tamai, S. Sekiguchi, and N. Shimizu Distribution of epidermal growth factor and epidermal growth factor receptor in human lung: immunohistochemical and immunoelectron-microscopic studies Respiration 61 3 1994 161 166 (Pubitemid 24157488)
15. S.M. Puddicombe, R. Polosa, A. Richter, M.T. Krishna, P.H. Howarth, and S.T. Holgate Involvement of the epidermal growth factor receptor in epithelial repair in asthma FASEB J 14 10 2000 1362 1374 (Pubitemid 30439745)
16. N.N. Nissen, P.J. Polverini, A.E. Koch, M.V. Volin, R.L. Gamelli, and L.A. DiPietro Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing Am J Pathol 152 6 1998 1445 1452 (Pubitemid 28275003)
17. S. Boussat, S. Eddahibi, A. Coste, V. Fataccioli, M. Gouge, and B. Housset Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells Am J Physiol Lung Cell Mol Physiol 279 2 2000 L371 L378
18. M.J. Pepels, K.A. Boomars, R. van Kimmenade, and P.S. Hupperets Life-threatening interstitial lung disease associated with trastuzumab: case report Breast Cancer Res Treat 113 3 2009 609 612
19. N. Cook-Bruns Retrospective analysis of the safety of Herceptin immunotherapy in metastatic breast cancer Oncology 61 Suppl. 2 2001 58 66 (Pubitemid 33033426)
20. B. Vahid, and A. Mehrotra Trastuzumab (Herceptin)-associated lung injury Respirology 11 5 2006 655 658 (Pubitemid 44186276)
21. L.C. Hanson, D.J. Weber, and W.A. Rutala Risk factors for nosocomial pneumonia in the elderly Am J Med 92 2 1992 161 166
22. J.U. Hedlund, A.B. Ortqvist, M.E. Kalin, and F. Granath Factors of importance for the long-term prognosis after hospital treated pneumonia Thorax 48 8 1993 785 789 (Pubitemid 23244338)
23. D.R. Kang, Y.K. Kim, M.S. Park, Y.S. Kim, D.H. Ko, and C. Kim Low levels of serum cholesterol and albumin and the risk of community-acquired pneumonia in young soldiers Int J Tuberc Lung Dis 12 1 2008 26 32